AuntMinnieEurope.com staff writersAIVara promotes results of AI breast cancer detection studyAn algorithm developed by artificial intelligence (AI) software developer Vara may correctly detect interval breast cancer, according to a study published in the European Journal of Radiology.May 3, 2022Industry NewsIBA acquires Modus Medical DevicesProton therapy developer Ion Beam Applications (IBA) has purchased Canadian dosimetry phantom provider Modus Medical Devices.May 2, 2022Clinical NewsHexarad introduces workflow management softwareU.K. teleradiology services provider Hexarad has launched OptiRad, a workflow management software application aimed at improving efficiency for radiology departments.May 2, 2022Clinical NewsU.K. seeks to develop apprenticeship schemeU.K. nonprofit organization Skills for Health is launching a small group to develop a diagnostic imaging option in the apprenticeship standard for a Senior Healthcare Support Worker.May 2, 2022Clinical NewsCIVCO plans new RT platform launch at ESTRORadiation therapy (RT) products provider CIVCO Radiotherapy will be introducing its TotalRT platform at the European Society for Radiotherapy and Oncology (ESTRO) meeting in Denmark this week.May 2, 2022ConferenceCaliberMRI to unveil quantitative MRI tool at ISMRM 2022Quantitative MRI technology developer CaliberMRI has unveiled a new feature that enables calibration of room-temperature MRI data. The company is showcasing the technology at this week's International Society for Magnetic Resonance in Medicine (ISMRM) meeting in London, England.May 2, 2022Clinical NewsEsaote reports increased revenue in 2021Italian ultrasound vendor Esaote reported increased revenue for its 2021 fiscal year.May 1, 2022Industry NewsLower sales of COVID tests drag down Hologic Q2 revenuesHologic reported revenue decreases for the second quarter of the 2022 fiscal year. The company said that lower sales of COVID-19 assays in its Diagnostics division was a major factor in the decline.May 1, 2022Industry NewsinHeart enrolls European patients for AI heart model trialMedical device company inHeart has began enrollment in Europe for a randomized control trial for the company's artificial intelligence (AI)-enabled digital twin of the heart.May 1, 2022AILunit's tumor analyzer receives CE MarkLunit said its Lunit SCOPE PD-L1, an artificial intelligence-based PD-L1 tumor proportion score analyzer, has received the CE Mark in Europe.April 28, 2022Previous PagePage 155 of 952Next PageTop StoriesWomens ImagingMammography screening improves survival for late-stage cancersWomen with screen-detected late-stage cancer have greater survival compared with women who do not undergo mammography screening.CTUsing GPT‑4o with CT exams helps diagnose ovarian cancer earlierMRIUnclear explanations of contrast MRI exams heighten patient anxietyMRI15 years of top stories: Which are the standouts?Molecular ImagingUnfilled vacancies and disparities persist in nuclear medicine
